Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Irritable Bowel Syndrome

  Free Subscription


18.06.2018

1 Aliment Pharmacol Ther
1 Am J Gastroenterol
1 Benef Microbes
1 BMC Res Notes
1 Clin Gastroenterol Hepatol
1 Epidemiol Infect
1 Expert Opin Drug Metab Toxicol
1 Expert Rev Gastroenterol Hepatol
1 J Clin Biochem Nutr
1 J Neurogastroenterol Motil
1 Mol Med Rep
1 Psychol Health Med
1 Rom J Intern Med
1 Tierarztl Prax Ausg K Kleintiere Heimtiere
2 United European Gastroenterol J
1 World J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. HANLON I, Hewitt C, Bell K, Phillips A, et al
    Systematic review with meta-analysis: online psychological interventions for mental and physical health outcomes in gastrointestinal disorders including irritable bowel syndrome and inflammatory bowel disease.
    Aliment Pharmacol Ther. 2018 Jun 14. doi: 10.1111/apt.14840.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. AZIZ I, Tornblom H, Palsson OS, Whitehead WE, et al
    How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0074.
    PubMed     Text format     Abstract available


    Benef Microbes

  3. PRESTON K, Krumian R, Hattner J, de Montigny D, et al
    Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
    Benef Microbes. 2018 Jun 11:1-10. doi: 10.3920/BM2017.0105.
    PubMed     Text format     Abstract available


    BMC Res Notes

  4. NEDI T, White PJ, Coupar IM, Irving HR, et al
    Effect of the 5-HT4 receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract.
    BMC Res Notes. 2018;11:362.
    PubMed     Text format     Abstract available


    Clin Gastroenterol Hepatol

  5. VIJAYVARGIYA P, Camilleri M, Chedid V, Carlson P, et al
    Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients with Chronic Functional Diarrhea.
    Clin Gastroenterol Hepatol. 2018 Jun 11. pii: S1542-3565(18)30603.
    PubMed     Text format     Abstract available


    Epidemiol Infect

  6. ESCOBEDO AA, Almirall P, Hanevik K, Cimerman S, et al
    Giardiasis: a diagnosis that should be considered regardless of the setting.
    Epidemiol Infect. 2018 Jun 11:1-3. doi: 10.1017/S0950268818001504.
    PubMed     Text format     Abstract available


    Expert Opin Drug Metab Toxicol

  7. BRUZZESE E, Pesce M, Sarnelli G, Guarino A, et al
    Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome.
    Expert Opin Drug Metab Toxicol. 2018 Jun 13. doi: 10.1080/17425255.2018.1488964.
    PubMed     Text format     Abstract available


    Expert Rev Gastroenterol Hepatol

  8. TURSI A
    A critical appraisal of advances in the diagnosis of diverticular disease.
    Expert Rev Gastroenterol Hepatol. 2018 Jun 9. doi: 10.1080/17474124.2018.1487288
    PubMed     Text format     Abstract available


    J Clin Biochem Nutr

  9. KATSUMATA R, Shiotani A, Murao T, Ishii M, et al
    The TPH1 rs211105 gene polymorphism affects abdominal symptoms and quality of life of diarrhea-predominant irritable bowel syndrome.
    J Clin Biochem Nutr. 2018;62:270-276.
    PubMed     Text format     Abstract available


    J Neurogastroenterol Motil

  10. LENHART A, Ferch C, Shaw M, Chey WD, et al
    Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of over 1500 United States Gastroenterologists.
    J Neurogastroenterol Motil. 2018 Jun 8. pii: jnm17116. doi: 10.5056/jnm17116.
    PubMed     Text format     Abstract available


    Mol Med Rep

  11. XIONG Y, Li KX, Wei H, Jiao L, et al
    Eph/ephrin signalling serves a bidirectional role in lipopolysaccharideinduced intestinal injury.
    Mol Med Rep. 2018 Jun 14. doi: 10.3892/mmr.2018.9169.
    PubMed     Text format     Abstract available


    Psychol Health Med

  12. CASSAR GE, Knowles S, Youssef GJ, Moulding R, et al
    Examining the mediational role of psychological flexibility, pain catastrophizing, and visceral sensitivity in the relationship between psychological distress, irritable bowel symptom frequency, and quality of life.
    Psychol Health Med. 2018 Jun 8:1-14. doi: 10.1080/13548506.2018.1476722.
    PubMed     Text format     Abstract available


    Rom J Intern Med

  13. LIVIU POP L, Muresan IA, Dumitrascu DL
    How much bloating in the irritable bowel syndrome?
    Rom J Intern Med. 2018.
    PubMed     Text format     Abstract available


    Tierarztl Prax Ausg K Kleintiere Heimtiere

  14. CERQUETELLA M, Rossi G, Spaterna A, Tesei B, et al
    Is irritable bowel syndrome also present in dogs?
    Tierarztl Prax Ausg K Kleintiere Heimtiere. 2018;46:176-180.
    PubMed     Text format     Abstract available


    United European Gastroenterol J

  15. CREMON C, Guglielmetti S, Gargari G, Taverniti V, et al
    Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial.
    United European Gastroenterol J. 2018;6:604-613.
    PubMed     Text format     Abstract available

  16. WILDER-SMITH CH, Olesen SS, Materna A, Drewes AM, et al
    Breath methane concentrations and markers of obesity in patients with functional gastrointestinal disorders.
    United European Gastroenterol J. 2018;6:595-603.
    PubMed     Text format     Abstract available


    World J Gastroenterol

  17. DEVANARAYANA NM, Rajindrajith S
    Irritable bowel syndrome in children: Current knowledge, challenges and opportunities.
    World J Gastroenterol. 2018;24:2211-2235.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: